Lv1
20 积分 2022-08-25 加入
Ustekinumab for the Treatment of Crohn‘s Disease
5天前
已完结
Ustekinumab for the Treatment of Crohn‘s Disease
5天前
已关闭
Ustekinumab for the treatment of psoriasis
5天前
已完结
Ustekinumab for the Treatment of Crohn‘s Disease
5天前
已关闭
Ustekinumab for the treatment of psoriasis
5天前
已关闭
Ustekinumab for the treatment of psoriasis
5天前
已关闭
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
9天前
已完结
IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway
24天前
已完结
ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis
24天前
已完结
A non-clinical comparative study of IL-23 antibodies in psoriasis
25天前
已完结
皖公网安备34019202002308
